MARLBOROUGH, Mass. /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City.
David Pierce, executive vice president and president, MedSurg and Susie Lisa, vice president, Investor Relations, will participate in a 60-minute roundtable discussion session with the host analyst beginning at approximately 9:30 a.m. EST. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.
A replay of the webcast will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investorsbeginning approximately one hour following the completion of the event.
CONTACTS
Media:
Investors:
Kate Haranis
Susie Lisa, CFA
508-683-6585 (office)
508-683-5565 (office)
Media Relations
Investor Relations
Boston Scientific Corporation
Boston Scientific Corporation
